LabGenomics Signs Supply Contract for COVID-19 Diagnostic Kits with Greece
[Asia Economy Reporter Minji Lee] LabGenomics, a molecular diagnostic healthcare specialist company, announced on the 10th that it has signed a supply contract for a novel coronavirus disease (COVID-19) diagnostic kit with a Greek company.
The company signed a contract with Asclepios, a Greek medical device specialist company, for the supply of COVID-19 diagnostic kits, with an initial quantity of 5,000 tests.
Asclepios is a company that supplies diagnostic equipment and products to medical institutions in Greece and Italy, maintaining business relationships not only in Greece but also with medical institutions in Italy, where confirmed COVID-19 cases have recently surged.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
A company representative stated, “Since there are inquiries from countries outside the Middle East and Europe as well, we will strive to achieve good results,” adding, “We will work to diversify overseas sales channels through the United Nations Global Marketplace (UNGM).”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
